Back to search results

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

Abroad (travel likely)Recruiting

Conditions

Epilepsy · Epilepsy (Treatment Refractory)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic - Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Neil Santos) · santos.neil@mayo.edu · 480-301-4252
    Contact: Principal Investigator (Corneila Drees, M.D)
    Jonathon Parker, M.D., Ph.D. (Sub-investigator)

  • Stanford, Palo Alto, California, United States

    Contact: Study coordinator (Adele Viviani) · aviviani@stanford.edu · 650-285-9180
    Contact: Principal Investigator (Jessica Falco-Walter, MD)

  • Stanford, Palo Alto, California, United States

    Contact: Study coordinator (Adele Viviani) · aviviani@stanford.edu · 650-285-9180
    Contact: Principal Investigator (Zahra Sadat Hossieny, MD)

  • Yale School of Medicine, New Haven, Connecticut, United States

    Contact: Study coordinator (Danielle Carlson) · danielle.carlson@yale.edu · 612-594-4080
    Contact: Principal Investigator (Aline Herlopian, M.D)

  • Mayo Clinic - Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Christina Cesta) · Cesta.Christina@mayo.edu · 904-953-5701
    Contact: Principal Investigator (William Tatum, D.O.)

  • Nicklaus Children's Hospital, Miami, Florida, United States

    Contact: Study coordinator (Juliana Montoya, RN, BSN, BS) · Juliana.Montoya@nicklaushealth.org
    Contact: Principal Investigator (Matt Lallas, MD)

  • USF Health, Tampa, Florida, United States

    Contact: Study coordinator (Marina Azevedo) · azevedom@usf.edu · 813-250-2323
    Contact: Principal Investigator (Ushtar Amin, MD)

  • IU Health Neuroscience Center, Indianapolis, Indiana, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Emory Peng) · epeng@mgh.harvard.edu · 617-975-8692
    Contact: Principal Investigator (Peter Hadar, MD, MS)

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Masumi Prasad) · mprasad2@bidmc.harvard.edu · 617-975-8684
    Contact: Principal Investigator (Niravkumar Barot, MD, MPH)

  • Mayo Clinic - Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Sherry Klingerman) · klingerman.sherry@mayo.edu · 507-284-0451
    Contact: Principal Investigator (Brian Lundstrom, M.D., Ph.D.)

  • Washington University, St Louis, Missouri, United States

    Contact: Study coordinator (Victoria Taylor, MD) · v.taylor@wustl.edu · 314-362-7871
    Contact: Study coordinator (Johanna Sonnenschein) · j.sonnenschein@wustl.edu · 314-273-8861
    Contact: Principal Investigator (Robert Hogan, M.D)

  • Atrium Health Neurosciences Institute - Charlotte, Charlotte, North Carolina, United States

    Contact: Study coordinator (Gina M'Buyamba) · Gina.MBuyamba@advocatehealth.org · 704-355-9434
    Contact: Principal Investigator (Rajdeep Singh, MD)

  • Duke University, Durham, North Carolina, United States

    Contact: Study coordinator (Lisa Gauger) · lisa.gauger@duke.edu · 919-668-1538
    Contact: Principal Investigator (Shruti Agashe, MD)

  • University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Kevin Hricik) · Kevin.Hricik@uhhospitals.org · 216-286-5295
    Contact: Study coordinator (Nathaly Contreras Cisneros) · Nathaly.ContrerasCisneros@UHhospitals.org · 216-844-2383
    Contact: Principal Investigator (Michael Staudt, M.D.)

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (T. Mindy Ganguly, MD) · epilepsyresearch@pennmedicine.upenn.edu · 215-662-7227
    Contact: Principal Investigator (T. Mindy Ganguly, M.D)
View source on ClinicalTrials.gov(opens in a new tab)